Effect of Clazakizumab on Neutrophil-Lymphocyte Ratio in Patients Receiving Hemodialysis: Secondary Analysis of the POSIBIL6ESKD Phase 2b Trial. Academic Article uri icon

Overview

publication date

  • February 13, 2026

Identity

Digital Object Identifier (DOI)

  • 10.2215/CJN.0000000995

PubMed ID

  • 41810906